LdhA, lactate dehydrogenase A; mAb(s), monoclonal antibody(ies); MAS, malateaspartate shuttle (MAS); MDHII, malate dehydrogenase II; NaCl, sodium chloride; NAD + , Nicotinamide adenine dinucleotide oxidized; NADH, Nicotinamide adenine dinucleotide reduced; NADP + , Nicotinamide adenine dinucleotide phosphate oxidized; NADPH, Nicotinamide adenine dinucleotide phosphate reduced; PCHO, Choline phosphate; Pdhk, pyruvate dehydrogenase kinase; PYC2, yeast pyruvate carboxylase TALENs, transcription activator-like effector nucleases; TCA, Tricarboxylic acid; tPA, tissue plasminogen activator; Txndc12, thioredoxin domain containing 12; ZFNs, zinc finger nucleases.
Introduction
Chinese Hamster Ovary (CHO) cells are the mammalian host of choice for the production of recombinant biological compounds. The market of therapeutic recombinant proteins presents cumulative sales values, ranging between $107 to $140 billion from 2010 to 2013 [1] . The first drug produced in this expression system was tissue plasminogen activator (tPA), which reached the marked in 1987 [1] . Examples of products expressed in CHO cells include erythropoietin (EPO) indicated for the treatment of severe anemia, coagulation factors as factor IX used as a therapeutic in hemophilia, interferon used for treating multiple sclerosis and monoclonal antibodies (mAbs) with the indication for treating Crohn's disease, different lymphomas, and cancers (e.g., breast and gastric cancer) [1] . From the biological drugs approved between 2006 and 2010, about 55% were produced in mammalian cells [2, 3] : from those between 2010 to the middle of 2014, 60% of the recombinant therapeutic proteins were also produced in mammalian cells. This shows an increasing trend which favors the use of expression systems of mammalian origin. Under the latter-mentioned time period, 33% of total approvals were for drugs expressed in CHO cells [1] . In retrospect, CHO cells have shown to be safe hosts and therefore, more likely to obtain approval for novel therapeutic proteins manufactured in this cell platform by the regulatory agencies.
The main advantages of using CHO cells compared to other microbial or mammalian cells [4] include the ability of these cells to perform post-translational modifications similar to those found in human proteins, such as glycosylation, which is considered to be a critical quality attribute. The presence of an aberrant glycan profile will decrease the efficacy [5] , affects the protein drug pharmacokinetics [6] , and alters biological properties [7] [8] [9] [10] . In addition, CHO cells have been demonstrated to display reduced susceptibility to human viral infections [11] , which represents an additional advantage over cell lines of human origin. Genomic and transcriptomic analysis of CHO-K1 showed that genes encoding for viral entry receptors, as well as other genes required for a successful viral infection, are absent or not expressed in the cell line [12] . CHO cells can grow in chemically defined medium, which reduces the chances for batch-to-batch variation and have the ability to be cultured in suspension, to facilitate the scale-up of the bioprocess [13] .
The metabolism of CHO cells, characterized by high uptake rates of substrates used as carbon and nitrogen sources [14] [15] [16] , is generally inefficient and suboptimal. The nutrients supplied in the media and feeds at certain concentrations may lead to the accumulation of metabolites, intermediates, and by-products. This indicates the existence of metabolic bottlenecks in key pathways and inefficient flux distribution. Furthermore, these accumulating compounds may decrease cell growth, productivity [17, 18] , and protein quality [19, 20] . As monitoring the metabolites and changing the related pathways has the potential to improve recombinant protein production in CHO cell culture, these 45 compounds are presented in a tabulated form ( Table 1 ). The table contains the main reports on the effects of the individual metabolites, and provides helpful primary references on e.g. the effect of concentrations of individual amino acids and sugars.
Furthermore, for some of these compounds, the reported effects are complex and surprising. To provide additional detail and context of these metabolites, we present overviews of the pathways for generation and consumption of the main toxic and inhibiting metabolites; glycolysis, the tricarboxylic acid (TCA) cycle, and amino acid metabolism, as well as glutathione metabolism. Moreover, some lipids have been shown to affect growth, for which we also discuss the details. In addition, we present methods and methodologies, which can be used to decrease or remove the presence of such toxic and inhibiting metabolites.
An Overview of CHO Metabolism
CHO cells have an inefficient metabolism, which is characterized by high uptake rates of substrates used as carbon and nitrogen sources (e.g., glucose and glutamine [14] ). The substrates are not fully used for production of biomass or recombinant proteins: thus, based on reports, 35% [21] and 70% [22] of glucose can be diverted into the formation of waste products, which impact the cell culture performance [15, 21, 22 ]. Examples of toxic or inhibiting metabolites can be found throughout metabolism [17] [18] [19] . Table 1 summarizes compounds that are reported to correlate with cell growth inhibition, apoptosis and/or have additional negative effect in culture due to accumulation or depletion. These metabolites are reporters of metabolic inefficiency and represent a waste of carbon diverting from the main metabolic pathways. Additionally, some of the listed metabolites function as alternative redox sinks (sorbitol, threitol, and glycerol), while others (amino acids) are catabolized instead of contributing directly to recombinant protein production and lead to the formation of toxic intermediates. In this review, we have chosen to focus on the main pathways where the majority of these compounds have been reported; glycolysis, the TCA cycle, amino acid metabolism, and glutathione (GSH) metabolism.
Central metabolism: nutrient uptake and by-product formation
The main carbon source in CHO cells is glucose, which is supplied in media and feeds that are used in batch and fed-batch bioprocesses. Glucose is taken up by the cell at high rates and phosphorylated to glucose-6-phosphate (G6P), and used in glycolysis to form adenosine triphosphate (ATP), reduced nicotinamide adenine dinucleotide (NADH) and pyruvate. Instead of proceeding to the full oxidation of glucose in aerobic conditions, pyruvate is converted into lactate along with the oxidation of NADH to oxidized nicotinamide adenine dinucleotide (NAD + ) by the action of lactate dehydrogenase A (LdhA). This represents a diversion of a flux of carbon away from the TCA cycle, to lessen the energy production and decrease production of important C4-6 precursors which are required for biomass formation (Figure 1 ). This phenomenon is also observed in cancer cells and called the Warburg effect [23] . For a better understanding of the relation between NAD + /NADH and glycolysis, we suggest reading the review by J. Locasale and L.
Canteley [24] .
As seen in Figure 1 , lactate is one of the main toxic metabolites found in central metabolism. The consequences of the accumulation of lactate in mammalian cell culture have been widely mentioned in the literature (Table 1 ). Reports have shown that lactate inhibits cell growth, induces apoptosis and reduces productivity of recombinant therapeutic products, due to changes in pH and osmolality [17, 18, [25] [26] [27] . Many other studies have explored the underlying motives for such phenotype [28] [29] [30] [31] [32] [33] [34] . In a bioprocess, two distinct phases of lactate metabolism have been described; initially, glucose consumption is accompanied by lactate production whilst, in later phases, the consumption of lactate is observed, although simultaneous consumption of glucose and lactate has likewise been described [29, 34] . It is important to note the link between lactate consumption phenotype and increased productivity [35] , as well as the metabolic shift from lactate production to lactate consumption as a marker of metabolic efficiency [33] . Reports show that initial lactate supplementation can induce a shift from high to low glycolytic flux, even in the presence of high glucose concentration [36] . When lactate is added into the medium along with pyruvate, glucose uptake rate was reduced by 50% [37] . For additional detail, the role of lactate has been extensively reviewed. We suggest the reader examines a set of particularly excellent reviews and research papers [15, 16, 28, 38] .
Alternative fates for carbon have also been suggested since glucose can also be converted into glycerol along with oxidation of NADH to NAD + , as well as sorbitol and threitol -in both cases, accompanied by the oxidation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) to oxidized nicotinamide adenine dinucleotide phosphate (NADP + ).
These compounds are formed from glycolytic intermediates and accumulate both intracellularly and extracellularly in the transition of the exponential to stationary phase of culture, after the addition of feed containing depleted nutrients (Table 1) [26, 39] .
Additionally, G6P is shunted away from glycolysis to enter the pentose phosphate pathway (PPP) where the sugar precursors are required for the synthesis of nucleotides, NADPH, and glycolytic intermediates are produced. The presence of nucleosides and nucleotidesadenosine, adenosine monophosphate (AMP), adenosine diphosphate (ADP), guanosine diphosphate (GDP), and guanosine monophosphate (GMP) -in the culture medium at low concentrations (1 mM) has shown to arrest cell growth and to contribute to protein production [40] . However, as specified in Table 1 , adenosine, ADP, and AMP have been reported to be cytotoxic. In particular, the extracellular concentrations of AMP as high as 2 mM become cytotoxic [40] while both AMP and GMP have been correlated with early apoptotic events in CHO cells [41] .
An oxidative metabolism is characterized by the channeling of the carbon molecules from glycolysis into the TCA cycle. Intermediates of the TCA cycle (citrate, succinate, fumarate and malate) accumulate during culture phases, which indicates a bottleneck (Table 1) (reviewed by Dickson [42] ). These intermediates were observed to build up in the cell culture medium after the addition of a feed, which contains pyruvate and amino acids (aspartate, asparagine and glutamate), and has been linked to growth limitation [26, 39, 43 ].
Amino Acid Metabolism in CHO Cell Culture
In CHO cell culture, amino acids are supplied in the growth medium and/or produced via biosynthetic pathways. These are required to support cellular functions, such as cell growth, and utilized as building blocks for protein synthesis [44, 45] . Through the catabolism of amino acids, the cell can utilize the carbon backbones for the formation of TCA cycle intermediates, which are to be used in the central metabolic pathways ( Figure  1 ). When these are supplied in excess, a wasteful cellular metabolism will lead to the formation of by-products, in particular ammonium. Ammonium is mainly formed from the breakdown of glutamine. The catabolism of several amino acids also leads to the formation of ammonium. This occurs via transamination reaction as an amino group is transferred to α-ketoglutarate and forming glutamate -that, in its turn, is deaminated to release ammonium ion, NH4 + [46] . Amino acids, such as Serine and Threonine, can undergo direct deamination. [46] . Ammonia has a negative impact on the product quality attributes when it accumulates and, similarly, affects productivity and cell growth [18-20, 25, 47, 48] . The mechanism by which ammonia affects growth is still not fully understood. It has been reported that the increasing concentration of ammonia modifies the electrochemical gradient and acidifies the intracellular milieu, which disrupts enzymatic activity and leads to apoptosis [18, 49] . Cell growth is inhibited in mammalian cell lines by ammonia concentrations ranging from 1.8 to 33 mM [50] . For CHO cells, cell growth inhibition has been reported for an ammonia concentration of 5.1 mM [25] and a reduction of 50% of growth was observed for ammonia concentrations were above 8 mM [51] . In an additional report, apoptotic cell death was not detected when CHO cells were exposed to 50 mM of ammonium chloride upon engineering of apoptotic genes [52] . Therefore, in a chemicallydefined medium, the initial amino acid concentrations should be well controlled and adjusted to the cell's specific metabolic requirements, based on prior studies of the cell line [50] .
Amino Acid Catabolism Leads to Formation of Toxic Intermediates
Changes in amino acid concentrations at defined culture phases have been correlated to cell growth inhibition and cell death. For example, asparagine consumption [26, 39, 53] has a negative effect in cell growth, [53, 54] , while alanine production [26, 39, 53] inhibits TCA cycle [53, 54] and also represents a source of ammonium [55] . In another study, lysine was supplied in excess in media formulations (considering a relatively low cell density) and accumulates during the death phase [56] . A more complete description is available in Table 1 . Interestingly, it has recently been shown that the catabolism of phenylalanine, tyrosine, tryptophan, methionine, leucine, serine, threonine, and glycine leads to the formation of nine intermediates (Table 1) , which are identified to be inhibiting cell growth [57, 58] . These metabolites should, in principle, be immediately converted to the next metabolite in the catabolic pathway and, thus, end up in the TCA cycle. However, the pathways are not optimally regulated and, thus, under conditions of low lactate and ammonia, and high cell density observed in the later stages of cultivation, "leak" the inhibiting compounds into the medium, where it accumulates. Furthermore, it was demonstrated that controlling the concentrations of these amino acids resulted in a reduction of the formation of inhibitory intermediates and improved cell growth and product titers during fed-batch cultivation for antibody production [57] .
Control of Lipid Metabolism is Required for Productive Cell Culture
A number of lipids have been shown to deplete or build up over time in CHO cell culture (Table 1 ). In particular, glycerolipids have been seen in multiple studies to affect growth in a variety of ways [26, 39, 42, 43, 59] . Choline phosphate (PCHO), glycero-3phosphocholine (G3PC), and glycerol-3-phosphate (G3P) have all been shown to build up in culture over time, which has been seen to lead to growth limitation in both fed-batch and batch cultures [26, 42, 43, 59] . This is an interesting phenomenon, as it suggests a poor regulation of glycerolipids and membrane composition in CHO cells.
PCHO has also been reported to deplete over time in longer cultivation, which also leads to growth limitations, possibly due to a resulting build up of G3P in the culture [59] . Finally, one can also see glycerol as linked to glycerolipids, despite the compound having many other functions in the cell, such as an osmotic regulator and a storage compound/redox sink [39] . As such, this makes the monitoring of glycerol over culture interesting, as it has been reported to also accumulate in the cells over culture [26] [43] . Given the many roles of glycerol, it is difficult to evaluate the reason or effect of this accumulation, but the ties with the redox potential of the cell and the possible links to lactate metabolism through NADH metabolism makes it an intriguing prospect.
Overall, the metabolism of glycerol and glycerolipids appear to be suboptimal in CHO cells and with possible growth-limiting or -arresting effects. It is thus clear that these aspects must be tightly controlled for optimal cell culture performance.
Glutathione Metabolism
Glutathione is a small abundant non-protein thiol, which is assembled from three amino acids found in eukaryotic cells [60, 61] . In mammals, its main role is to act as a protective molecule against oxidative stress by transitioning between the oxidized (GSSG) and reduced (GSH) form of the molecule (Figure 2 ), and have as such been linked to cellular stress responses. In particular, glutathione participates in redox signaling, detoxification of xenobiotics, regulation of cell proliferation, apoptosis, and is involved in immune function events [60, 62] . While GSH and GSSG are important for the overall cellular metabolism, we focused on the key mechanism regarding recombinant protein production in this review.
Biosynthesis of Glutathione
The de novo biosynthesis of GSH takes place in the cytosol, as the first reaction is catalyzed by the enzyme glutamate-cysteine ligase (Gcl) which assembles the amino acids cysteine and glutamate at the cost of one ATP to form γ-glutamyl-cysteine -this represents the rate-limiting step in this pathway. Gcl is an enzyme composed of two subunits that are coded by two different gene sequences as seen in higher eukaryotes -these subunits are the catalytic (Gclc) and the modifier (Gclm). Gcl activity is regulated by the concentration of GSH present in the cell in a feedback inhibition manner [63] . Furthermore, the availability of cysteine, as it donates the sulphur from its sidechain, represents another important limiting factor in the biosynthesis of GSH. The second step in the generation of GSH is catalysed by the enzyme glutathione synthase (Gss) where glycine is added to γglutamyl-cysteine, also at the cost of one ATP to form γ-L-glutamyl-L-cysteinyl-glycine -GSH ( Figure 2 ).
As GSH interacts with reactive oxygen species and other redox proteins, it is converted into glutathione disulphide (GSSG), where two molecules of GSH are required to form one GSSG. The salvage pathway of glutathione formation occurs when GSSG is reduced back to GSH in a reaction catalyzed by glutathione-disulfide reductase (Gsr) which requires the availability of NADPH as a co-factor, along with the magnesium ion Mg 2+ . Posttranslational regulation of Gcl involves modifications of Gclc via phosphorylation, caspasemediated cleavage, which may have a mild impact on overall Gcl activity [64] .
Additionally, NADP + and NADPH can also modulate Gcl activity in vitro [64] . Glutathione, additionally, can detoxify the cell from the toxic compound methylglyoxal (Table 1) , which is formed spontaneously as its free form reacts with GSH [65].
Glutathione in the Context of Recombinant Protein Production
During the production of recombinant proteins, the cell metabolism is characterized by high glycolytic metabolism during cell growth, while maximum antibody production is associated with a more oxidative metabolism [21] . Due to their high proliferative nature, CHO cells may experience increased levels of oxidative stress and, consequently, require higher levels of GSH [66, 67] , as observed in most types of cancer cells. Chong et al. [41] used a metabolomics approach with LC-MS analysis for the identification of compounds which induced apoptosis in a fed-batch cultivation of a mAb-producing CHO cell line. The shortlisted extracellular metabolites which correlated with intracellular caspase activity were GSSG, AMP, GMP, and amino acid derivatives, which included dimethylarginine and acetylphenylalanine ( Table 1 ). In particular, the presence of GSSG in the medium resulted in an increased fold-change in caspase activity, which showed a strong link between GSSG accumulation and the early signal of apoptotic cell death. This observation suggests that GSSG is an additional cause for cell death in prolonged cell cultures, other than those linked to lactate and ammonia. In a subsequent study, the group defined the GSH as a marker of productivity, as high mAb producers have high intracellular GSH content [68] .
This same trait was observed in CHO cells that produced a different mAb in a study which combined different proteomics methods to determine differentially expressed proteins [69] . Interestingly, this study has also shown that, amongst other pathways, glutathione biosynthesis enzymes were upregulated in the producer cells. The engineering strategy developed by the same group is further discussed in section 4.
Metabolomics as an Evaluator of Presence of Growth-inhibiting and Toxic

Metabolites
Metabolomics allows the quantitative analysis of metabolites that are present inside and outside the cell, and provides evidence regarding which pathways and reactions are active in the cell under given culture conditions [70] [71] [72] . Metabolomics represents a complement to other 'omics [73] , since the data gathered from these investigations can also be integrated into metabolic models. While metabolic profiling is employed when a small set of metabolites that are linked to a phenotype is known, metabolomics is employed to measure and identify all possible metabolites and, consequently, explore hitherto undetermined metabolic links to a phenotype [34] . Thus the cell metabolome, along with the other 'omics data, can inform which cellular events are responsible for a specific phenotype (e.g., high protein producer). When reviewing metabolomics in the context of recombinant protein expression, Dickson [42] has argued that the interpretation of these data sets can potentially assist in the identification or generation of the best producer cells, either via cell engineering and/or the optimization of media and feeds. Moreover, the raw materials can be controlled using metabolomics approaches and therefore, minimize batch-to-batch variations, as part of bioprocess development. This methodology is indeed central for understanding CHO cell metabolism and, when employed in combination with other 'omics data, gives a snapshot of the cell's metabolic state.
Online Resources for Metabolism
In order to continually follow the updates in CHO metabolism and identify new growthinhibiting and toxic metabolites, a number of online resources are helpful.
www.CHOgenome.org is the access point for all publicly available genome-wide data of Chinese hamster and CHO cell lines [74] . Similarly, the CHOmine (https://chomine.boku.ac.at) is a data warehouse for CHO data with analysis tools.
Additionally, CHOmine provides links to external websites and integrates recently published genome scale models (GEMs) [75] . Such models, developed by a consortium of researchers, allow for the integration 'omics data -genomics, transcriptomics, proteomics and metabolomics -for guiding hypothesis-driven discovery and metabolic engineering [76] . The GEMs are also excellent sources for an overview of CHO metabolites as models specifically developed for CHO cells exist and can support cell line engineering approaches and CHO cells' bioprocesses [77] . An earlier model [59] allowed for the identification of growth limiting factors and is available at http://CHO.sf.net (v1.1). More recently, the constraint-based models of Chinese hamster and CHO cell lines (CHO-S, CHO-K1 and CHO-DG44) were made available to researchers in the CHO field and can be downloaded from http://bigg.ucsd.edu/models/iCHOv1 and www.CHOgenome.org [77] .
Additional useful databases are the metabolic database Kyoto Encyclopedia of Genes and Genome (KEGG) (http://www.kegg.jp), Reactome (http://www.reactome.org) and the Human Metabolome Database (HMDB) (http://www.hmdb.ca). KEGG provides information about metabolites and genes coding for enzymes which catalyze reactions participating in biochemical pathways [78] [79] [80] . Reactome is a tool for the visualization of the reactions, networks in the context of cellular compartments where anabolic and catabolic pathways occur [81] . Detailed information about small molecule metabolites that are present in the human body [82] [83] [84] can be found in HMDB. This database can hint to which metabolites might affect CHO cells in culture, based on the toxic effects of the molecules to human cells, tissues, or organs.
In conclusion, the resources presented in Table 2 can aid and provide clues for medium development and for finding targets for engineering cells with improved phenotypes, based on the avoidance of unwanted metabolites.
Cell Line Engineering for Improved Nutrient Metabolism
Many strategies for cell line engineering have been employed in attempts to tackle the problematic of metabolic waste products which arise during cell culture, most extensively towards lactate production. The reviews by Ficher and colleagues [85] and Kim et al. [2] gather a number of cell line engineering approaches that were carried out in CHO cells. We briefly discuss cell line engineering approaches carried out in CHO cells which resulted in reduced lactate production. Reports have demonstrated the potential of engineering CHO cells, as seen in the case of the LdhA gene that was downregulated using RNAi technology, yielding reduced lactate production rates without impacting cell growth nor productivity of human thrombopoietin [86] . Similar results were observed with the downregulation of LdhA and pyruvate dehydrogenase kinase (Pdhk) isoenzymes 1, 2, and 3 in antibody producing-CHO cells [87] . However, the knockout of LdhA using zinc finger nucleases (ZFNs) in cells where Pdhk 1, 2, and 3 was down regulated was revealed to be lethal [88] .
The overexpression of Aralar1, part of malate-aspartate shuttle (MAS), in a lactateproducing cell line led to a metabolic shift from lactate production to consumption [89] .
This way, the authors found a link between MAS and this metabolic shift. Other investigational work involved the stable expression of fructose transporter (GLUT5) [90] .
When cells used this sugar as a carbon source, the uptake rate of fructose was such (low) that the overflow of excess carbon to lactate was avoided. A number of research articles describe the effects of overexpressing the enzyme pyruvate carboxylase. The overexpression of yeast pyruvate carboxylase (PYC2) resulted in a significant decrease in lactate production and increase in productivity [91] . An identical outcome was observed when human pyruvate carboxylase was engineered using a similar approach [92] . In a more recent study, the overexpression of codon optimized PYC2, reduced lactate production, and improved mAb production and glycosylation [93] . Additionally, improved cell metabolism was observed with the overexpression of malate dehydrogenase II (MDHII), which lead to an increase in intracellular ATP and NADH, and integral viable cell number [94] . The LC-MS analysis of the extracellular metabolites revealed the accumulation of malate, which was a result of an excess supply of aspartate in the medium and the presence of a bottleneck in MDHII in the TCA cycle.
More recently, the glutathione biosynthesis pathway was engineered through the stable overexpression of Gclc, which yielded increased GSH concentrations but did not improve productivity [95] . However, when the modifier subunit of Gcl was stably overexpressed in CHO host cells, an increase in specific productivity was observed once a mAb was transiently expressed by these cells. Surprisingly, the findings of this work allowed the conclusion that the GSH content does not contribute to the improvement of productivity of mAb in CHO cells, contrary to what was previously stated [68, 69] .
Furthermore, the development of glutamine synthetase (GS) selection system exemplifies an important advance in recombinant protein expression using CHO cells, representing an alternative to dihydrofolate reductase (DHFR) expression system. The GS system is based on the knockout of the gene encoding for GS, which is reintroduced into the cell along with the vector encoding for recombinant protein [96] . The cells grow in glutamine freemedium under the selection pressure of methionine sulfoximine (MSX). An additional advantage of the GS system is that it allows for the reduction of by-product formation, as once the GS gene is reintroduced, ammonia along with glutamate is utilized to form of glutamine. Glutamine becomes available for the formation of TCA cycle intermediates such as α-ketoglutarate.
Applications and future perspectives
In upstream process development for the production of recombinant therapeutic protein, both media and feed design, and cell line engineering can be employed. Cell line-or clonespecific media optimization may be required for each shortlisted candidate that is generated in one cell line development experiment, as these may display different growth phenotypes and by-product levels, as well as to account for the effects of clone-medium interactions [97] .
The quantification of toxic metabolites in cell culture can aid the media development efforts, by indicating which precursor media and feed components are required to be supplied in controlled amounts. However, while media and feed optimization has enabled achievement of higher cell densities and increased productivity, it is still far from challenging the cell's maximized growth and production capacity that is predicted by metabolic network models. Metabolomics, along with other 'omics, provides an extra layer of knowledge on the cell metabolism and can lead to breakthroughs that improve these parameters. For instance, after the identification of toxic metabolic intermediates, such as the ones presented in Table 1 , one can employ cell engineering tools to limit the formation of these inhibitory molecules. The metabolic pathways where these compounds are involved should be analyzed for identification of the target genes. Thereafter, it is essential to select the most suitable engineering strategy to perform specific genomic changes (e.g. downregulation or deletions of genes, or the overexpression of heterologous pathways that convert the toxic intermediates into "safer" molecules) for targeting genes encoding [23] O. Warburg, On the Origin of Cancer Cells. Science (80-. ) . 1956, 123, 309. [26] [42] [43] Ammonia C00014 Decreases specific cell growth rate, increases consumption rates of glucose and glutamine and decrease antibody product titer in hybridoma cells.
Affects intracellular pH, cell growth and recombinant protein productivity, and product glycosylation.
Reduces of growth rates and maximal densities, changes metabolic rates, affects protein processing in mammalian cells.
Production of ammonia and alanine is linked to the consumption of asparagine and glutamine in a GS-CHO cell line.
Amino acid metabolism [18] [100]
[20] [53] Asparagine C00152 Asparagine consumption has been correlated with accumulation of ammonia and alanine. Accumulated in the medium along with alanine, in the transition of exponential phase to stationary Recommended to keep concentration bellow 0,5-1 mM in fed-batch process due to growth inhibition.
Accumulation of glycine is beneficial for the cells due to its role in GSH biosynthesis.
Glycine, Serine and Threonine metabolism [43] [53]
[26] [57] [58]
[59] Leucine C00123 Recommended to keep concentration bellow 0,5-1 mM in fed-batch process due to growth inhibition. 
C00020
Cytotoxic: induces apoptosis when added to cell culture medium at 2mM, in at lower concentrations (1mM) arrests cell growth and increases productivity. Increased metabolic capacity of the cell.
Purine metabolism;
Signaling pathways [40] Arrests cell cycle in G1 in CHO cells overexpressing p27, a CDK inhibitor, and increased SEAP specific productivity.
Addition to fresh CHO mAb cultures lead to apoptosis.
[108]
[41]
Adenosine triphosphate (ATP)
C00002
Cytotoxic: induces apoptosis in cells of the immune system, nervous system and endothelium. Increased metabolic capacity of the cell.
Arrests cell cycle in G1 in CHO cells overexpressing p27, a CDK inhibitor, and increased SEAP specific productivity.
Purine metabolism;
Oxidative phosphorylation [40] [108] guanosine diphosphate (GDP)
C00035
Leads to cell growth arrest. Purine metabolism, Signaling pathways [40] Guanosine monophosphate (GMP)
C00144
Added to culture medium and decreased cell growth. This effect was shown not to be cell line dependent. May improve protein production after arresting cell growth.
Purine metabolism, Signaling pathways [40] [41]
Lipid metabolism
Choline phosphate (PCHO)
C00588
Depleting over time (144h) in fed-batch cultivation; linked to the build-up of extracellular G3PC and to cell growth limitation.
By-product of choline, builds up after 72 h of cultivation. Glycero-3phosphocholine (G3PC)
C00670
Builds-up over time as intracellular precursors of PE and PC deplete; linked to cell growth limitation.
By-product of choline, builds up after 72 h of cultivation.
Glycerophosphol ipid metabolism [59] [43]
Redox metabolites GSSG C00127 Addition to fresh CHO mAb cultures lead to apoptosis. Linked to oxidative stress; potential growth-limiting factor.
Accumulates extracellularly towards the end of the culture.
Glutathione metabolism [41] [59] 
